Mankind Pharma Pvt Ltd
Brand: Mankind Pharma Pvt Ltd
Availability: In Stock
Price: USD $29.00
* Packages:

Rating : 2 reviews

Manforce 50 mg tablet belongs to the group called phosphodiesterase type 5 inhibitors. This 50 mg tablet is used to treat impotency in men also known as Erectile dysfunction. This tablet is manufactured by Mankind Pharma Ltd.

Active Ingredient:
The active component in this medicine is Sildenafil Citrate which enhances the blood flow in the penile region which causes the penile erection in men for long-lasting intercourse activity.

The effectiveness of this medicine can be experienced in 30 minutes of consumption. This medicine helps in enhancing the blood flow in the penile region by which a man can achieve and sustain with a stiffer penile for a long time. With erect penile, men can perform a sexual activity for long hours. Manforce 50 can last for up to 5 hours, hence always talk to your doctor regarding the dosage and continuity of the drug. If taken in the correct amount of proportion, this medicine can help men to have complete sexual satisfaction despite facing impotency.

It is also important to note that Manforce 50 does not offer any protection against sexually transmitted diseases such as syphilis, gonorrhea, HIV, etc. So, adequate safety measures should be taken while having sexual intercourse. Overconsumption of this medicine may lead to severe side effects. The side effects can be stomach upset, back pain, muscle pain, stuffy nose, flushing, or dizziness. You must call your doctor or reach a nearby medical facility if you are suspecting any symptoms due to overdose like prolonged and painful erection of more than 4 hrs, pain during urination, swelling, body pain, etc. Avoid consuming alcohol while taking this medicine. Also, avoid driving any vehicle because you may feel sleepy with this medicine.


Write a review

Your Name:

Your Review: Note: HTML is not translated!

Rating: Bad            Good

Enter the code in the box below:

Logos and trademarks remain the property of the corresponding companies. © 2021